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The role of the GABA transporter in acute toxicity in chick retina due to metabolic inhibition was 
investigated by the use of several substrate (nipecotic acid, THPO) and nonsubstrate (SKF 89976A, 
NO711) GABA transport inhibitors. Metabolic stress-induced acute toxicity in the retina is 
characterized by swelling of distinct populations of retinal neurons and selective release of GABA 
into the medium. Inhibitor concentrations were based on that needed to attenuate 14C-GABA 
uptake at its approximate KM concentration by _>70%. Under basal conditions, substrate, but not 
nonsubstrate, inhibitors increased extracellular GABA, but did not cause histological swelling per  
se. Under conditions of glycolytic inhibition, nonsubstrate, but not substrate, inhibitors significantly 
attenuated acute toxicity. Metabolic stress-induced acute toxicity was not altered by the GABA 
agonist muscimol, nor did muscimol reverse the protective effects of nonsubstrate transport 
inhibitors, suggesting that an increase in extracellular GABA during metabolic stress was not a 
component of the acute phase of toxicity. The results indicate that during metabolic inhibition, 
activity at the GABA transporter contributes to acute cellular swelling. © 1997 Elsevier Science Ltd 
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INTRODUCTION 
Impairment of energy metabolism in retina from several 
species produces damage that is mediated, at least in part, 
by NMDA receptors (David, Lusky, & Teichberg, 1988; 
Yoon & Marmor, 1989; Zeevalk & Nicklas, 1991; 
Mosinger, Price, Bai, Xiao, Wozniak, & Olney, 1991). 
Acutely, impairment of either glycolysis or oxidative 
phosphorylation i chick retina causes swelling of 
distinct populations of retinal neurons found mainly in 
the inner layers of the retina, i.e., amacrine cells in the 
inner half of the inner nuclear layer, cells in the ganglion 
cell layer and processes in the inner plexiform layer 
(David et al., 1988; Zeevalk & Nicklas, 1990; Zeevalk & 
Nicklas, 1991). This acute swelling is positively 
correlated with a selective net increase in GABA in the 
extracellular medium (Zeevalk, Hyndman, & Nicklas, 
1989). Acute swelling (David et al., 1988; Zeevalk & 
Nicklas, 1990; Zeevalk & Nicklas, 1991) and the increase 
in extracellular GABA (Zeevalk & Nicklas, 1990; 
Zeevalk & Nicklas, 1991) caused by energy impairment 
is prevented by agents which block NMDA receptors. 
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Long-term derangements produced by energy impair- 
ment in the retina are also attenuated byNMDA (Yoon & 
Marmor, 1989). 
Recently, our laboratory reported that in the chick 
retina, blocking the GABA transporter with SKF 
89976A, a nonsubstrate GABA transport inhibitor 
attenuated acute GABA release produced by the 
excitotoxin glutamate (Zeevalk & Nicklas, 1996). Un- 
expectedly, SKF 89976A also greatly reduced cellular 
swelling, suggesting that activity at the GABA transpor- 
ter during excitotoxin exposure contributes to the acute 
cellular edema. Since glutamate r ceptors are involved in 
acute toxicity produced by inhibition of ene, rgy metabo- 
lism in the retina, the present work sought to determine if 
inhibiting the GABA transporter during energy impair- 
ment would attenuate acute damage. To better character- 
ize the role of the GABA transporter in mediation of 
acute swelling during metabolic inhibition, several 
substrate and nonsubstrate inhibitors were examined. 
MATERIALS AND METHODS 
Retinal dissection and incubations conditions during 
metabolic impairment 
Retina were isolated from embryonic (E) day 14/15 
White Leghorn chickens as previously described (Zee- 
valk et al., 1989). Briefly, retina were isolated in a 
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bicarbonate buffered Krebs Ringer (KRB) prewarmed to 
37°C and pregassed with 5% CO2-95%O2 to adjust he 
pH to 7.4. KRB consisted of (in raM): 119 NaC1, 4.8 KC1, 
25 MOPS buffer, 1.7 CaC12, 1.2 KH2PO4, 1.2 MgSO4, 
5.5 glucose, and 23.8 sodium bicarbonate, pH 7.4. 
Extraocular tissue was removed and the central posterior 
retina excised. The isolated retina was transferred via a 
teflon coated spatula to a beaker containing 3 ml of fresh 
KRB. The tissue was preincubated at370C with gentle 
shaking and constant gassing in a Dubnoff Shaker bath 
for 10 rain, then transferred tofresh KRB and inhibition 
of glycolysis was initiated by the addition of 1 mM 
iodoacetate (IOA). GABA transport inhibitors, 
SKF89976A (kind gift of SmithKline Beecham, Spring- 
house, PA), NO711 (RBI, Natick, MA), nipecotic acid 
(Sigma Chemical Co., St. Louis MO) and 4,5,6,7- 
tetrahydrois-oxazolol[4,5-c]pyridin-3-ol (THPO, Sigma 
Chemical Co.), or the GABA agonist muscimol (Sigma 
Chemical Co.) was present during the preincubation a d 
incubation periods. Incubations with IOA with or without 
other additives were carried out for 45 rain. At the 
conclusion of the experiment, the medium was used for 
GABA determination and the tissue for histology or 
protein measurement. 
14 C-GABA uptake 
Isolated retina were preincubated in KRB at 37°C for 
10 min. The medium was removed and replaced with 
1 ml KRB plus 14C-(U)-GABA (0.05/~Ci n 5.235/IM 
total GABA) with or without one of the GABA transport 
inhibitors: SKF89976A (10, 100#M), NO711 (10, 
100/tM), nipecotic acid (0.5, l mM), THPO (3, 
10 mM), or the GABAA agonist muscimol (100#M). 
Uptake was carried out for 10 rain at 37°C. At the end of 
incubation, the medium was collected, the tissue washed 
with cold 0.1 M MgCI2 and the radioactivity in the tissue 
extracted with 0.4 N perchloric acid. Background was 
determined by measuring t4C-GABA uptake in retina 
placed on ice for 10min prior to the addition of 
radioactivity. Background counts were subtracted from 
all other eadings. 
GABA determination 
At the end of incubation, the medium was acidified 
with perchloric acid (0.4 N final concentration). Prior to 
measurement, the samples were neutralized to pH 5.9 
with K2CO2. GABA in the medium was quantified by 
fluorescent detection of the a-phthalaldehyde adduct by 
HPLC as previously described (Zeevalk et al., 1989). 
Protein in the tissue was measured by the procedure of 
Lowry, Rosebrough, Farr, & Randall (1951) and GABA 
levels expressed as #mol/100 mg protein (---equivalent 
to gram of tissue). 
Histology 
At the end of incubation, retinal tissue was fixed in 3% 
glutaraldehyde in KRB, dehydrated through a graded 
series of alcohols and embedded in JB-4 (Polyscience 
Inc.) under vacuum in flat embedding molds. Five 
micrometer sections, six per retina were :mounted onto 
slides and stained with 0.1% cresyl violet for viewing. At 
least two retina per condition were examined for 
histology. When GABA levels in the medium were 
measured from tissue used for histology, an average 
protein value was used. Protein values raeasured over 
numerous dissections did not differ by more than 4-10%. 
Statistics. Data were analyzed by analy,;is of variance 
and significance was determined by the Student-New- 
man Kuels multiple comparisons post hoc test. 
RESULTS 
Two nonsubstrate GABA transporter inhibitors, 
SKF89976A and NO711, and two GABA transport 
inhibitors known to be subgtrates for the transporters, 
nipecotic acid and THPO, were tested for their ability to 
inhibit 14C-GABA uptake in isolated E15 chick retina 
(Table 1). The concentrations reported in Table 1 and 
then used for subsequent studies were those that 
provided >_70% inhibition of high affinity GABA uptake. 
Consistent with findings from previous tudies, inhibi- 
tion of glycolysis with iodoacetate for 45 rain produced 
an acute toxicity that was characterized byacute swelling 
of distinct populations of retinal neurons, most notably, 
amacrine cells in the inner half of the inner nuclear layer 
and cells in the ganglion cell layer. Neuritic processes in 
the inner plexiform layer were acutely swollen, providing 
a spongy appearance to this retinal ayer (Fig. 1). Most 
cells in the outer half of the retina, i.e., bipolar and 
horizontal cells in the outer half of the inner nuclear layer 
and photoreceptor cells in the outer nuclear layer were 
relatively unaffected. As previously demonstrated (Zee- 
valk & Nicklas, 1990), acute histological changes were 
accompanied by a net increase in extracellular GABA 
(Fig. 2). The GABA transport inhibitors, SKF 89976A 
and NO711, which block the transporter but do not act as 
substrates, provided substantial ttenuation of the acute 
histological swelling (Fig. 1) as well as significant 
reduction in net extracellular GABA at the conclusion 
of 45 rain of glycolytic blockade [Fig. 2(A)]. In contrast, 
GABA transport inhibitors that competed with GABA as 
substrates for the transporter, neither provided protection 
against he acute cellular swelling (Fig. 1) nor the net 
TABLE 1. The effect of GABA transport inhibitors on the uptake of 
14C-GABA 
Condition n pmol/mg protein (±:sem) % of control 
Control 3 467 ± 38 100 
SKF 89976A 3 130 4- 35 28 
NO711 3 78 4- 22 17 
Nipecotic acid 3 132 + 5 28 
THPO 3 142 4- 17 30 
Isolated E14/15 retina were incubated in bicarbonate buffered Krebs 
Ringer containing 14C-GABA (0.05 #Ci in 5.23/tM total GABA) 
plus either SKF 89976A (100#M), NO711 (100pM, nipecotic 
acid (1 mM) or THPO (10 raM) for 10 rain at 37°C. Radioactivity 
in the tissue was determined by scintillation counting of acid 
treated extracts. 






FIGURE 1. Light micrographs of isolated E14/15 retina incubated in (a) KRB or KRB plus (b) 1 mM iodoacetate (IOA); (c) 
IOA and SKF 89976A (100 #M); (d) IOA and nipecotic acid (Nip, 1 raM); (e) IOA and NOT11 (100 #M); or (f) IOA and THPO 
(10 mM) for 45 min at 37°C. Inhibition of glycolysis with IOA for 45 min produced cell swelling predominately in the inner 
layers of the retina (inner INL and GCL) and in processes in the IPL. GABA transport inhibitors, SKF 89976A and NO711, that 
do not ride the carrier (c, e) greatly attenuated IOA-induced swelling, whereas ubstrate transport inhibitors, Nip and THZPO, (d) 
and (f), respectively, did not reduce swelling. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nucle~ layer; 
IPL, inner plexiform layer; GCL, ganglion cell layer. 
increase in extracel lular GABA [Fig. 2(B)] produced by 
inhibit ion of glycolysis.  
GABA transport inhibitors such as nipecotic acid, 
which serve as substrates for the transporter, have been 
shown to release GABA via a heteroexchange process 
(Johnston, Stephanson, & Twitchin, 1976; Solis & Nicoll,  
1992). To examine whether this occurred :in retina, and 
whether reversal of  the GABA transporter, under 
condit ions of normal energy metabol ism, resulted in 
acute cel lular swell ing, E l5  retina were :incubated for 
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FIGURE 2. Matched pairs of isolated E14/15 retina (i.e., left and right retina from the same embryo) were incubated with the 
glycolytic inhibitor iodoacetate (IOA, 1 mM) for 45 min at 37°C plus either (A) a nonsubstrate GABA transport inhibitor, SKF 
89976A (100/~M) or NO711 (100/zM); or (B) a substrate transport inhibitor, nipecotic acid (Nip, l mM) or THPO (10 mM). At 
the end of incubation, the GABA in the medium was analyzed by HPLC as described in Methods. Nontransported GABA uptake 
inhibitors (A), but not substrate inhibitors (B) attenuated the IOA-induced rise in extracellular GABA. Basal extracellular 
GABA levels in this set of experiments were below the level of detection (0.005/zmol/100 mg protein). N is from three to four 
separate determinations per condition. *Different from IOA alone. P < 0.05 or better, ANOVA with Student-Newman Kuels 
post hoc test. 
45 min in medium containing various transport inhibitors 
at concentrations that inhibited GABA uptake by >70%: 
SKF89976A (100/~M), NO711 (100 #M), nipecotic acid 
(1 mM) or THPO (10 mM). As shown in Fig. 3, the 
nonsubstrate transport inhibitors SKF89976A or NO711 
did not elevate GABA levels above control, whereas the 
substrate inhibitors THPO or nipecotic acid significantly 
elevated extracellular GABA. Nipecotic acid or THPO- 
induced GABA efflux per se, however, did not result in 
cellular swelling (Fig. 4), suggesting that under condi- 
tions of normal energy metabolism reversal of the GABA 
transporter for prolonged intervals was not sufficient to 
produce acute toxicity. 





SKF NO711 THPO NIP Basal 
FIGURE 3. E14/15 retina were incubated in KRB for 45 rain at 37°C 
with one of the following GABA transport inhibitors: 100/zM SKF 
89976A, 100 #M NO711, l0 mM THPO or 1 mM nipecotic acid (Nip). 
At the end of incubation, GABA levels in the medium were measured 
by HPLC. Only transport inhibitors that act as substrates for the 
transporter caused a net increase in extracellular GABA. N is from 
three to four determinations per condition. *Different from control. 
immediate stages following inhibition of energy meta- 
bolism may trigger activation of GABAA receptors and 
result in C1- influx. Acute neuronal swelling during the 
early stages of excitotoxicity has been shown to be 
dependent on extracellular CI- (Olney, l:h'ice, Samson, & 
Labruyere, 1986). We, therefore, examined whether the 
increase in extracellular GABA found during metabolic 
inhibition in retina contributed to acute toxicity by an 
action at the GABAA receptor. GABA receptor activity 
during metabolic stress was modulated by incubation 
with the GABAA receptor agonist, muscimol (100/tM). 
Muscimol had no effect on high affinity GABA uptake 
(313 vs 391 + 3.0 pmol/mg protein -t- SEM for Iac- 
GABA uptake in control and 100/~M muscimol-treated 
retina, respectively, (n is from two control and three 
muscimol-treated r tinas). As shown in Table 2 and Fig. 
4, activation of the GABAA receptor did not alter acute 
toxicity produced by IOA treatment. Further, the 
presence of muscimot was not able to reverse the 
protective ffect of SKF 89976A during IOA treatment 
(Table 2). Histology of retina treated with muscimol plus 
IOA and SKF 89976A appeared similar to IOA plus SKF 
89976A without muscimol (not shown). 
DISCUSSION 
The major finding from the current work is that the: 
blockade of the GABA transporter during energy 
impairment reduces acute cellular swelling and the 
concomitant increase in extracellular GABA. The find- 
ings also demonstrate that he bulk of the GABA released 
acutely from the retina during metabolic inhibition is a 
consequence of reversal of the GABA transporter. 
Previous work has shown that SKF 89976A, a non- 
transportable GABA uptake inhibitor, blocks acute cell 
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FIGURE 4. Light micrographs of isolated E14/15 retina incubated for 45 min at 37°C in KRB plus (a) 100/zM SKF 89976A; (b) 
1 mM Nip; or (c) 1 mM IOA and 100 #M muscimol. Under conditions of normal metabolism, neither nonsubstrate GABA 
transport inhibitors (a) nor substrate inhibitors (b) caused ceil swelling per se. NO711 and THPO gave similar results (data not 
shown). The GABAA agonist muscimol did not attenuate the acute swelling produced by IOA treatment. 
swelling and GABA efflux by glutamate, indicating 
GABA transporter reversal due to excitotoxicity (Zeevalk 
& Nicklas, 1996). Since acute damage in the chick retina 
during glycolytic inhibition is mediated by NMDA 
receptors (David et al., 1988; Zeevalk & Nicklas, 
1991), reversal of the transporter during metabolic 
inhibition is probably a downstream consequence of 
NMDA receptor involvement. Glutamate mediated- 
GABA release via reversal of the transporter has been 
demonstrated in a variety of neuronal cell types (Weiss, 
1988; Pin & Bockaert, 1989; Harris & Miller, 1989; 
Dunlop, Grieve, Schousboe, & Griffiths, 1991; Belhage, 
Hansen, & Schousboe, 1993), including retina (Schwartz, 
1982; Yazulla & Kleinschmidt, 1983; Jonsson, Lund- 
strom, Sellstrom, & Ehinger, 1986; Hofmann & Mockel, 
1991) and may serve both physiological (Schwartz, 1982) 
and pathophysiological roles. 
SKF 89976A, a derivative of nipecotic acid, is not 
transported by the GABA uptake carrier. It can, however, 
gain entrance into the cell due to its lip0philicity 
(Larsson, Falch, Krogsgaard-Larson, & Schousboe, 
1988). Extracellular or intracellular application of SKF 
89976A has been shown to block GABA transporter- 
mediated currents (Takahashi, Miyoshi, Kaneko, & 
Copenhagen, 1995), indicating that SKF 89976A can 
work on either the trans or cis side of the carrier. Thus, 
the protective ffect of SKF 89976A may be the result of 
a direct blockade of the transporter f om either the 
extracellular or cytoplasmic surface. The current study 
does not address the issue of polarity for the action of 
SKF 89976A. NO711, a lipophilic guavicine derivative 
had a similar protective ffect o SKF 89976A, making it 
likely that the action of the nonsubstrate GAB A transport 
blockers was the result of a specific aclion at the 
transporter. SKF 89976A does not alter glutamate- 
induced changes in 22Na influx (Zeevalk & Nicklas, 
1996) or [Ca]i (Belhage, Hansen, & Schousboe, 1993). 
NO711 has been shown to lack affinity for a variety of 
neurotransmitter receptor or transporter systems (Suzdak, 
Frederiksen, Andersen, Sorensen, Knutsen, & Nielsen, 
1992), further supporting a specific action of the 
compounds at the GABA carrier site. 
Protection from metabolic stress-induced acute toxi- 
city was found with GABA transport inhibitors that were 
not substrates for the transporter (SKF 89976A, NO711), 
whereas uptake inhibitors, such as nipecotic acid and 
THPO, which are themselves transported and efflux 
GABA, were not protective. This observation raised the 
question as to the link between the increase in 
extracellular GABA and acute cellular edema following 
excitotoxicity or metabolic inhibition. Both nipecotic 
acid and THPO caused efflux of GABA into the medium 
(Fig. 3) most likely through a heteroexchange process 
(Johnston et al., 1976; Solis & Nicoll, 1992). Nipecotic 
acid and THPO did not increase GABA efflux above that 
seen with energy blockade alone. This finding suggests 
TABLE 2. Modulation of the GABAA receptor during inhibition of 
glycolysis 
Condition n Extracelhlar GABA 
(pmol/100 mg prot.± SEM) 
Control 6 N.D. 
Muscimol 3 N.D. 
IOA 3 0.299 :q- 0.020 
IOA + muscimol 3 0.298 :+ 0.016 
IOA + SKF 89976A 3 0.028 :+ 0.003* 
IOA + muscimol + SKF 3 0.029 + 0.003* 
89976A 
Retina were incubated with 1 mM IOA for 45 min at 37°C in the 
presence or absence of muscimol (100#M), SKF 89976A 
(100 #M) or both. At the end of incubation, extracellular GABA 
in the medium was determined by HPLC. Muscimol neither 
attenuated IOA-induced GABA release, nor reversed the attenuat- 
ing effects of SKF 89976A on IOA-induced GABA release. 
*Different from IOA alone, P < 0.05 or better, ANOVA with 
Student-Newman Keuls post hoc test. N.D., not detected. 
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that under conditions of energy block, reversal of the 
transporter may be occurring at some maximal rate. 
Under conditions of normal metabolism, the efflux of 
GABA by nipecotic acid or THPO did not cause cellular 
swelling. However, the situation may be different with 
energy compromise or excitotoxicity. Acute swelling 
resulting from excitotoxicity is known to be Na + and C1- 
dependent (Olney et al., 1986). An increase in extra- 
cellular GABA, and activation of GABAA receptors 
would lead to an increase in C1- conductance, which may 
further contribute to osmotic imbalance and H20 intake. 
To address the role of the increase in extracellular GABA 
during the acute phase of metabolic inhibition, retina 
were exposed to the GABA agonist muscimol during 
glycolytic impairment. Acute toxicity during metabolic 
impairment was unaltered by the presence of muscimol. 
In addition, muscimol did not reverse the protective 
effect of SKF 89976A during metabolic inhibition, which 
would have been expected if the increase in extracellular 
GABA was contributing to acute toxicity via activation 
of GABAA receptors. This finding points to activity at the 
GABA transporter rather than efflux of GABA per  se as 
being the important mediator in the acute toxic response 
to metabolic stress. Alternatively, GABAc receptors may 
also be a source of C1- movement. However, since 
muscimol is also a potent agonist at GABAc receptors 
(Buckingham, Hosie, Roush, & Sattelle, 1994), they 
seem unlikely to play a role in this regard. More detailed 
studies with selective agonists are required to further 
elucidate this point. 
The ability of nonsubstrate vs substrate transport 
inhibitors to attenuate cellular edema caused by meta- 
bolic stress or excitotoxicity may be related to blockade 
of the ion flow that accompanies GABA through the 
transporter. GABA transport requires the presence of 
Na + and C1- and is electrogenic, but can operate 
asymmetrically and with variable stoichiometry (Cam- 
mack, Rakhilin, & Schwartz, 1994). Ion movement 
through the transporter can also occur in the absence of 
GABA (Cammack et al., 1994). Further, nonsubstrate 
inhibitors produce no current hemselves and suppress 
GABA-induced currents, whereas substrate transport 
inhibitors evoke a current response (Takahashi et al., 
1995), consistent with the interpretation that nonsubstrate 
inhibitors protect by blocking ionic movements. The 
transporter may thus be an important source for Na + and 
C1- movement during excitotoxicity or metabolic stress 
in retina and may contribute to ionic imbalance and 
subsequent swelling. Alternatively, energy demands 
during metabolic derangement may be further compro- 
mised by prolonged activity of the transporter t ying to 
clear GABA from the extracellular environment. To this 
end, blocking the activity of the GABA transporter may 
help to maintain energy status. This possibility is 
currently being addressed in the laboratory. 
At present, there are four distinct, cloned GABA 
transporters; GAT-1, GAT-2, GAT-3 and BGT-1 (see 
Borden, Murali Dhar, Smith, Weinshank, Branchek, & 
Gluchowski, 1994 for discussion). SKF 89976A, NO711 
and nipecotic acid have greater affinity for GAT-1 as 
compared with the other transporters (Borden et al., 
1994). GAT-1 mRNA has been found in pure neuronal 
and mixed glial cell cultures (i.e., astrocytes, oligoden- 
drocytes and microglia), but not in pure astrocyte cultures 
(Gomeza, Gimenez, & Zafra, 1994). In rat retina, GAT- 
1 mRNA is expressed in amacrine, displaced amacrine, 
interplexiforrn cells and some ganglion cells (Brecha & 
Weigmann, 1994). Miiller cells also express GAT-1, but 
at low levels relative to neurons. Honda, Yamamoto, & 
Saito (1995) demonstrated three subtypes of GABA 
transporters in rat retina: GAT-1, GAT-2 and GAT-3. 
GAT-1 was located predominately in the inner part of the 
inner nuclear layer and the inner plexiform layer, whereas 
GAT-3 appeared to be primarily associated with Mtiller 
cells. Thus, it might be speculated that in retina, SKF 
89976A, NO711 and nipecotic acid inhibited the GABA 
transporter found primarily in retinal neurons of the inner 
layers of the retina. Since the bulk of the increase in 
extracellular GABA during metabolic stress is from 
reversal of the transporter, these observations would 
suggest that the release of GABA is coming predomi- 
nately from neuronal pools within the inner layers of the 
retina. THPO is a well known glial specific uptake 
inhibitor (Schousboe, Hjeds, Krogsgaard-Larsen, & 
Wood, 1986). Given that neither THPO (predominately 
glial) nor nipecotic acid (predominately neuronal) 
protected against acute toxicity vs metabolic stress, 
whereas SKF 89976A and NO711 did, the issue of 
neuronal vs glial uptake inhibition appears less important 
than whether or not the inhibitor is transported by the 
carder. 
Muscimol, the GABAA agonist had neither a detri- 
mental nor beneficial effect on the acute: toxicity found 
with metabolic impairment in this model. At very high 
concentrations (500/~M), muscimol has been shown to 
inhibit GABA transport in transfected CHO cells (Corey, 
Guastella, Davidson, & Lester, 1994). Muscimol at the 
concentration used in this study (100 #M) did not inhibit 
GABA uptake, consistent with findings in skate retina 
(Malchow & Ripps, 1990) and, therefore, any action at 
this site can be ruled out. Since our studies do not directly 
assess a physiological effect of muscimol on GABAA 
receptors, it is possible that the failure of muscimol to 
modify metabolic stress-induced acute toxicity was due 
to an ineffective response at the receptor. Several studies 
have shown that muscimol is an effectiw~ anticonvulsant 
or protective agent vs stroke/ischemia (Schousboe, 
Larsson, Wood, & Krogsgaard-Larsen, 1983; Nielsen, 
Suzdak, Andersen, Knutsen, Sonnewald, & Braestrup, 
1991; Shuaib, Mazagri, & Ijaz, 1993; Madden, 1994; 
Lyden & Lonzo, 1994; Suzdak & Jansen, 1995). 
Increasing extracellular GABA would provide protection 
by hyperpolarizing cells and decreasing activity. One 
strategy for elevating extracellular GABA levels is by 
blocking GABA transporters. Nonsubstrate ransporters 
are efficacious anticonvulsants (Nielsen et al., 1991; 
Suzdak & Jansen, 1995) and have the added advantage 
over substrate transporters in that they cross the blood- 
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brain barrier more readily due to their lipophilic nature. 
Although nonsubstrate transport inhibitors do not efflux 
GABA per se, they block the reuptake of GABA released 
from other sources to increase extracellular GABA 
(Waldmeier, Stocklin, & Feldtrauer, 1992). The use of 
GABA transport blockers in models of hypoxia/ischemia 
or hypoglycemia has not been previously addressed. 
During the initial stages of metabolic stress, swelling of 
cellular elements can decrease the extracellular space and 
increase the concentration of potentially excitable 
extracellular constituents, such as K + or excitatory 
amino acids. Nonsubstrate GABA transport blockers 
may have a dual benefit in situations of naetabolic 
compromise such as stroke/ischemia, hypoxia or hypo- 
glycemia. In addition to hyperpolarizating cells to 
decrease activity, nonsubstrate blockers would reduce 
the acute cellular swelling that accompanies metabolic 
inhibition of neural tissue to further minimize neuronal 
damage. 
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